Delivery Order SPE2DR25D9239-SPE2DR26FFBK5
- Not listed
- The Defense Logistics Agency awarded a $25,111 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and requires performance at the contractor's Park Ridge facility. The award carries no set-aside designation, indicating the contractor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,394.12 to DMS Pharmaceutical Group Inc. for 500 microgram vials of Nplate on September 24, 2025. This firm fixed-price delivery order, which must be completed by October 16, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. Nplate is a prescription...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Nplate 500 microgram vials, with a ceiling value of $20,091.18. This firm fixed-price delivery order is set to conclude by October 7, 2025, and represents a discrete pharmaceutical product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract involves no set-aside designation, and fulfillment will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nplate 250 microgram vials. This $1,673.67 firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes no set-aside designation and is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- The Defense Logistics Agency awarded a $10,042.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of NPLATE 250 micrograms vials. The delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order...
- The Defense Logistics Agency awarded a $10,042.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 250 microgram vials of Nplate. The delivery order, issued May 12, 2025, with completion targeted for June 3, 2025, carries no set-aside designation. DMS Pharmaceutical Group leverages its position as a woman-owned small business to compete in federal procurement while fulfilling this...
- The Defense Logistics Agency awarded a delivery order valued at $8,368.35 to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of Nplate 250 microgram vials. This firm fixed-price delivery order is expected to be completed by October 8, 2025, with fulfillment from the contractor's facilities in Park Ridge, Illinois. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for 250 microgram vials of Nplate, valued at $8,368.35, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform the work at its Park Ridge location and deliver the pharmaceutical product to support federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,389.36 to DMS Pharmaceutical Group Inc. for the supply of Nplate 250 microgram vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its facility in Park Ridge, IL, with an ultimate completion date of August 11, 2025. The award was issued on July 21, 2025, and does not include a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,736.70 by the Defense Logistics Agency on October 20, 2025, for the supply of Nplate 250 mcg vials. This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBK5Delivery Order
The Defense Logistics Agency awarded a $3,416.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 250 microgram vials of Nplate. The award, issued on November 11, 2025, carries an ultimate completion date of December 3, 2025, and was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has served as a critical supplier within the federal pharmaceutical supply chain since its System for Award Management registration in 2001, with its PPV-G GEN V contract awarded on November 13, 2025, featuring a $499.999 billion ceiling and extending through December 31, 2036. The contractor's extensive product portfolio includes branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals supporting the diverse medical supply needs of military healthcare operations globally. The delivery order for Nplate represents routine pharmaceutical provisioning under this broader contract vehicle, positioning DMS Pharmaceutical Group to fulfill specialized and recurring pharmaceutical requirements for Department of Defense medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 11/11/25 |